Skip to main content
SpringerLink
Log in

Infections Complicating Cardiothoracic Surgery and Cardiac Devices

  • Chapter
  • First Online:
Healthcare-Associated Infections in Children

  • 755 Accesses

Abstract

Innovations in surgical techniques and medical technology have allowed for the improved survival and quality of life of children with complex congenital heart disease as well as those with arrhythmias and cardiomyopathies. With increased interventions to aid these children comes the potential for risk of complex infections associated with surgery and implantation of devices and hardware. The management of such infections is often challenging and requires a multidisciplinary approach including infectious diseases specialists, cardiologists, and surgeons. This chapter briefly reviews surgical site infections, including mediastinitis, in children undergoing cardiothoracic surgery as well as infections complicating cardiac implantable electronic devices and ventricular assist devices.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Levy I, Ovadia B, Erez E, Rinat S, Ashkenazi S, Birk E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect. 2003;53(2):111–6.

    Article  CAS  Google Scholar 

  2. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–6.

    Article  Google Scholar 

  3. Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37(10):783–805.

    Article  Google Scholar 

  4. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.

    Article  Google Scholar 

  5. Allpress AL, Rosenthal GL, Goodrich KM, Lupinetti FM, Zerr DM. Risk factors for surgical site infections after pediatric cardiovascular surgery. Pediatr Infect Dis J. 2004;23(3):231–4.

    Article  Google Scholar 

  6. Mehta PA, Cunningham CK, Colella CB, Alferis G, Weiner LB. Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J. 2000;19(10):1000–4.

    Article  CAS  Google Scholar 

  7. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. Am J Infect Control. 2010;38(9):706–10.

    Article  Google Scholar 

  8. McNeil JC, Ligon JA, Hulten KG, Dreyer WJ, Heinle JS, Mason EO, et al. Staphylococcus aureus infections in children with congenital heart disease. J Pediatric Infect Dis Soc. 2013;2(4):337–44.

    Article  Google Scholar 

  9. Sarvikivi E, Lyytikainen O, Nieminen H, Sairanen H, Saxen H. Nosocomial infections after pediatric cardiac surgery. Am J Infect Control. 2008;36(8):564–9.

    Article  Google Scholar 

  10. Murray MT, Krishnamurthy G, Corda R, Turcotte RF, Jia H, Bacha E, et al. Surgical site infections and bloodstream infections in infants after cardiac surgery. J Thorac Cardiovasc Surg. 2014;148(1):259–65.

    Article  Google Scholar 

  11. Krizek TJ, Robson MC. Evolution of quantitative bacteriology in wound management. Am J Surg. 1975;130(5):579–84.

    Article  CAS  Google Scholar 

  12. Edwards MS, Baker CJ. Median sternotomy wound infections in children. Pediatr Infect Dis. 1983;2(2):105–9.

    Article  CAS  Google Scholar 

  13. Long CB, Shah SS, Lautenbach E, Coffin SE, Tabbutt S, Gaynor JW, et al. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J. 2005;24(4):315–9.

    Article  Google Scholar 

  14. Tortoriello TA, Friedman JD, McKenzie ED, Fraser CD, Feltes TF, Randall J, et al. Mediastinitis after pediatric cardiac surgery: a 15-year experience at a single institution. Ann Thorac Surg. 2003;76(5):1655–60.

    Article  Google Scholar 

  15. Al-Sehly AA, Robinson JL, Lee BE, Taylor G, Ross DB, Robertson M, et al. Pediatric poststernotomy mediastinitis. Ann Thorac Surg. 2005;80(6):2314–20.

    Article  Google Scholar 

  16. Barker GM, O’Brien SM, Welke KF, Jacobs ML, Jacobs JP, Benjamin DK Jr, et al. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg. 2010;89(3):843–50.

    Article  Google Scholar 

  17. Kagen J, Lautenbach E, Bilker WB, Matro J, Bell LM, Dominguez TE, et al. Risk factors for mediastinitis following median sternotomy in children. Pediatr Infect Dis J. 2007;26(7):613–8.

    Article  Google Scholar 

  18. Costello JM, Graham DA, Morrow DF, Morrow J, Potter-Bynoe G, Sandora TJ, et al. Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg. 2010;89(6):1833–41; discussion 1841–2

    Article  Google Scholar 

  19. Harder EE, Gaies MG, Yu S, Donohue JE, Hanauer DA, Goldberg CS, et al. Risk factors for surgical site infection in pediatric cardiac surgery patients undergoing delayed sternal closure. J Thorac Cardiovasc Surg. 2013;146(2):326–33.

    Article  Google Scholar 

  20. Shah SS, Lautenbach E, Long CB, Tabbutt S, Gaynor JW, Bilker WB, et al. Staphylococcus aureus as a risk factor for bloodstream infection in children with postoperative mediastinitis. Pediatr Infect Dis J. 2005;24(9):834–7.

    Article  Google Scholar 

  21. Fowler VG Jr, Kaye KS, Simel DL, Cabell CH, McClachlan D, Smith PK, et al. Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation. 2003;108(1):73–8.

    Article  Google Scholar 

  22. Exarhos DN, Malagari K, Tsatalou EG, Benakis SV, Peppas C, Kotanidou A, et al. Acute mediastinitis: spectrum of computed tomography findings. Eur Radiol. 2005;15(8):1569–74.

    Article  CAS  Google Scholar 

  23. Jolles H, Henry DA, Roberson JP, Cole TJ, Spratt JA. Mediastinitis following median sternotomy: CT findings. Radiology. 1996;201(2):463–6.

    Article  CAS  Google Scholar 

  24. Yamashiro T, Kamiya H, Murayama S, Unten S, Nakayama T, Gibo M, et al. Infectious mediastinitis after cardiovascular surgery: role of computed tomography. Radiat Med. 2008;26(6):343–7.

    Article  Google Scholar 

  25. Ugaki S, Kasahara S, Arai S, Takagaki M, Sano S. Combination of continuous irrigation and vacuum-assisted closure is effective for mediastinitis after cardiac surgery in small children. Interact Cardiovasc Thorac Surg. 2010;11(3):247–51.

    Article  Google Scholar 

  26. Anslot C, Hulin S, Durandy Y. Postoperative mediastinitis in children: improvement of simple primary closed drainage. Ann Thorac Surg. 2007;84(2):423–8.

    Article  Google Scholar 

  27. Ohye RG, Maniker RB, Graves HL, Devaney EJ, Bove EL. Primary closure for postoperative mediastinitis in children. J Thorac Cardiovasc Surg. 2004;128(3):480–6.

    Article  Google Scholar 

  28. Siegman-Igra Y, Shafir R, Weiss J, Herman O, Schwartz D, Konforti N. Serious infectious complications of midsternotomy: a review of bacteriology and antimicrobial therapy. Scand J Infect Dis. 1990;22(6):633–43.

    Article  CAS  Google Scholar 

  29. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004;147(4):582–6.

    Article  Google Scholar 

  30. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669–75.

    Article  Google Scholar 

  31. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45(2):166–73.

    Article  Google Scholar 

  32. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, et al. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences. J Cardiovasc Electrophysiol. 2010;21(7):786–90.

    PubMed  Google Scholar 

  33. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17(5):767–77.

    Article  Google Scholar 

  34. Cohen MI, Bush DM, Gaynor JW, Vetter VL, Tanel RE, Rhodes LA. Pediatric pacemaker infections: twenty years of experience. J Thorac Cardiovasc Surg. 2002;124(4):821–7.

    Article  Google Scholar 

  35. Chen SY, Ceresnak SR, Motonaga KS, Trela A, Hanisch D, Dubin AM. Antibiotic prophylaxis practices in pediatric cardiac implantable electronic device procedures: a survey of the pediatric and congenital electrophysiology society (PACES). Pediatr Cardiol. 2018;39(6):1129–33.

    Article  Google Scholar 

  36. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851–9.

    Article  Google Scholar 

  37. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010;7(8):1043–7.

    Article  Google Scholar 

  38. Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM, et al. Outcomes in patients with cardiovascular implantable electronic device infection managed with chronic antibiotic suppression. Clin Infect Dis. 2017;64(11):1516–21.

    Article  Google Scholar 

  39. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012;110(8):1143–9.

    Article  Google Scholar 

  40. Hussein AA, Baghdy Y, Wazni OM, Brunner MP, Kabbach G, Shao M, et al. Microbiology of cardiac implantable electronic device infections. JACC Clin Electrophysiol. 2016;2(4):498–505.

    Article  Google Scholar 

  41. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503–51.

    Article  Google Scholar 

  42. Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30(4):1072–8.

    Article  Google Scholar 

  43. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098–107.

    Article  CAS  Google Scholar 

  44. Granados U, Fuster D, Pericas JM, Llopis JL, Ninot S, Quintana E, et al. Diagnostic accuracy of 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: a cross-sectional study. J Nucl Med. 2016;57(11):1726–32.

    Article  CAS  Google Scholar 

  45. Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP, et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart. 2012;98(9):724–31.

    Article  Google Scholar 

  46. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678–85.

    Article  Google Scholar 

  47. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.

    Article  CAS  Google Scholar 

  48. Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB, et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015;132(15):1487–515.

    Article  Google Scholar 

  49. Peacock JE Jr, Stafford JM, Le K, Sohail MR, Baddour LM, Prutkin JM, et al. Attempted salvage of infected cardiovascular implantable electronic devices: are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018;41(5):524–31.

    Article  Google Scholar 

  50. Hogness JR, Van Antwer M. The artificial heart program: current status and history. In: Hogness JR, Van Antwer M, editors. The artificial heart: prototypes, policies and patients. Washington, DC: National Academy Press; 1991. p. 14–25.

    Google Scholar 

  51. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43.

    Article  CAS  Google Scholar 

  52. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis. 2006;6(7):426–37.

    Article  Google Scholar 

  53. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867–76.

    Article  CAS  Google Scholar 

  54. Almond CSD, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119(5):717–27.

    Article  Google Scholar 

  55. Fraser CD Jr, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, et al. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367(6):532–41.

    Article  CAS  Google Scholar 

  56. Cabrera AG, Khan MS, Morales DL, Chen DW, Moffett BS, Price JF, et al. Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant. 2013;32(5):518–24.

    Article  Google Scholar 

  57. Blume ED, VanderPluym C, Lorts A, Baldwin JT, Rossano JW, Morales DLS, et al. Second annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report: pre-implant characteristics and outcomes. J Heart Lung Transplant. 2018;37(1):38–45.

    Article  Google Scholar 

  58. Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis. 2002;34(10):1295–300.

    Article  Google Scholar 

  59. Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127(6):691–702.

    Article  Google Scholar 

  60. Nienaber JJ, Kusne S, Riaz T, Walker RC, Baddour LM, Wright AJ, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57(10):1438–48.

    Article  Google Scholar 

  61. Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90(4):1270–7.

    Article  Google Scholar 

  62. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30(4):375–84.

    Article  Google Scholar 

  63. Auerbach SR, Richmond ME, Schumacher KR, Lopez-Colon D, Mitchell MB, Turrentine MW, et al. Infectious complications of ventricular assist device use in children in the United States: data from the pediatric interagency registry for mechanical circulatory support (Pedimacs). J Heart Lung Transplant. 2018;37(1):46–53.

    Article  Google Scholar 

  64. Rosenthal DN, Almond CS, Jaquiss RD, Peyton CE, Auerbach SR, Morales DR, et al. Adverse events in children implanted with ventricular assist devices in the United States: data from the pediatric interagency registry for mechanical circulatory support (PediMACS). J Heart Lung Transplant. 2016;35(5):569–77.

    Article  Google Scholar 

  65. Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784–91.

    Article  Google Scholar 

  66. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283.

    Article  CAS  Google Scholar 

  67. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control. 1999;27(2):97–132; quiz 133–4; discussion 196.

    Article  CAS  Google Scholar 

  68. O'Hara LM, Thom KA, Preas MA. Update to the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee guideline for the prevention of surgical site infection (2017): a summary, review, and strategies for implementation. Am J Infect Control. 2018;46(6):602–9.

    Article  Google Scholar 

  69. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26.

    Article  CAS  Google Scholar 

  70. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9–17.

    Article  CAS  Google Scholar 

  71. Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31(11):1151–7.

    Article  Google Scholar 

  72. Kusne S, Staley L, Arabia F. Prevention and infection management in mechanical circulatory support device recipients. Clin Infect Dis. 2017;64(2):222–8.

    Article  Google Scholar 

  73. Saraswat MK, Magruder JT, Crawford TC, Gardner JM, Duquaine D, Sussman MS, et al. Preoperative Staphylococcus Aureus screening and targeted decolonization in cardiac surgery. Ann Thorac Surg. 2017;104(4):1349–56.

    Article  Google Scholar 

  74. Ninh A, Weiner M, Goldberg A. Healthcare-associated mycobacterium chimaera infection subsequent to heater-cooler device exposure during cardiac surgery. J Cardiothorac Vasc Anesth. 2017;31(5):1831–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA

    Jesus G. Vallejo, J. Chase McNeil & Judith R. Campbell

Authors
  1. Jesus G. Vallejo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Chase McNeil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judith R. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jesus G. Vallejo .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA

    J. Chase McNeil

  2. Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA

    Judith R. Campbell

  3. Department of Pediatrics, Baylor College of Medicine and The Children’s Hospital of San Antonio, San Antonio, TX, USA

    Jonathan D. Crews

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vallejo, J.G., McNeil, J.C., Campbell, J.R. (2019). Infections Complicating Cardiothoracic Surgery and Cardiac Devices. In: McNeil, J., Campbell, J., Crews, J. (eds) Healthcare-Associated Infections in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-98122-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98122-2_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98121-5

  • Online ISBN: 978-3-319-98122-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation